Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells

This study was performed to evaluate the anticancer effects of tolerable doses of metformin with or without medroxyprogesterone (MPA) in endometrial cancer cells. Cell viability, cell invasion, and levels of matrix metallopeptidase (MMP) and transforming growth factor (TGF)-β1 were analyzed using th...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Dong Hoon, Lee, Sunray, Park, Hyun-Sook, Park, Noh Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694768/
https://www.ncbi.nlm.nih.gov/pubmed/33172126
http://dx.doi.org/10.3390/jcm9113585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694768/
https://www.ncbi.nlm.nih.gov/pubmed/33172126
http://dx.doi.org/10.3390/jcm9113585

Ejemplares similares